Steva Pljesa
Overview
Explore the profile of Steva Pljesa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Djukanovic L, Dimkovic N, Marinkovic J, Andric B, Bogdanovic J, Budosan I, et al.
Nefrologia
. 2015 Aug;
35(3):287-95.
PMID: 26299172
Objectives: The aims of the study were to determine the percentage of patients on regular hemodialysis (HD) in Serbia failing to meet KDOQI guidelines targets and find out factors associated...
2.
Suvakov S, Damjanovic T, Pekmezovic T, Jakovljevic J, Savic-Radojevic A, Pljesa-Ercegovac M, et al.
BMC Nephrol
. 2014 Jan;
15:12.
PMID: 24423050
Background: The presence of glutathione transferase (GST) M1 null genotype (GSTM1-null) in end-stage renal disease (ESRD) patients is associated with lower overall survival rate in comparison to those with GSTM1-active...
3.
Suvakov S, Damjanovic T, Stefanovic A, Pekmezovic T, Savic-Radojevic A, Pljesa-Ercegovac M, et al.
Nephrol Dial Transplant
. 2012 Oct;
28(1):202-12.
PMID: 23034843
Background: Increased oxidative stress is a hallmark of end-stage renal disease (ESRD). Glutathione S-transferases (GST) are involved in the detoxification of xenobiotics and protection of oxidative damage. We hypothesized that...
4.
Rabrenovic V, Poskurica M, Kovacevic Z, Nesic V, Savin M, Mitic B, et al.
Kidney Blood Press Res
. 2010 Jul;
33(4):297-303.
PMID: 20664209
Background/aims: Mycophenolate mofetil (MMF) has been increasingly used for the treatment of lupus nephritis (LN). The aim of this study was to examine the efficacy and safety of MMF used...
5.
Krivoshiev S, Wizemann V, Czekalski S, Schiller A, Pljesa S, Wolf-Pflugmann M, et al.
Adv Ther
. 2010 Apr;
27(2):105-17.
PMID: 20369312
Introduction: The primary objective of the trial was to prove the therapeutic equivalence of epoetin zeta to epoetin alfa when administered subcutaneously for maintaining target hemoglobin (Hb) in patients with...
6.
Dimkovic N, Jovanovic D, Kovacevic Z, Rabrenovic V, Nesic V, Savin M, et al.
Nephron Clin Pract
. 2009 Feb;
111(3):c189-96.
PMID: 19194109
Background/aims: Glucocorticoids and classic immunosuppressive drugs can improve disease activity in primary glomerulonephritis (GN). However, these drugs have serious toxicity and patients frequently experience inadequate response or relapse, so there...
7.
Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Ilic M, Stokic E
Med Pregl
. 2008 Oct;
60 Suppl 2:33-8.
PMID: 18928154
We investigated the effect of body composition, nutrition, inflammation and iron status on insulin resistance in patients with long-term hemodialysis. We selected 43 stable end-stage chronic renal failure patients, on...
8.
Pljesa-Ercegovac M, Mimic-Oka J, Dragicevic D, Savic-Radojevic A, Opacic M, Pljesa S, et al.
Urol Oncol
. 2008 Mar;
26(2):175-81.
PMID: 18312938
Purpose: We aimed to discern the role of glutathione (GSH) associated enzymes in maintaining high GSH levels in renal cell carcinoma (RCC) of the clear cell type and analyze RCC...
9.
Pljesa S
Med Pregl
. 2007 Sep;
60(3-4):123-7.
PMID: 17853722
Introduction: Renal anemia is a very common finding in patients with chronic kidney disease (CKD), both in patients not yet requiring dialysis and in patients on hemodialysis. Erythropoietin therapy is...
10.
Rasic-Milutinovic Z, Perunicic G, Pljesa S, Gluvic Z, Ilic M, Stokic E
Intern Med
. 2007 Jul;
46(13):945-51.
PMID: 17603231
Objective: Insulin resistance and metabolic syndrome (MeS) are common in end-stage renal disease (ESRD) patients on maintenance hemodialysis (HD). Such metabolic and clinical abnormalities may lead to an increased risk...